Pay in 4 interest-free payments of $5.93 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Projected timelines from industry analysts suggest: Phase 3 trials may begin in late 2024 or 2025
Your healthcare provider will need to provide supporting documentation highlighting your diagnosis, treatment history, and why Wegovy is necessary for you
Preclinical studies suggest that acetylcarnitine attenuates oxidative stress and neuroinflammation [2, 112]
Factors which could cause actual results to differ materially from those estimated by the Company include, but are not limited to, government regulation and regulatory approvals, managing and maintaining growth, the effect of adverse publicity, litigation, competition, scientific discovery, the patent application and approval process, potential adverse effects arising from the testing or use of products utilizing the DehydraTECH technology, the Companys ability to maintain existing collaborations and realize the benefits thereof, delays or cancellations of planned R&D that could occur related to pandemics or for other reasons, and other factors which may be identified from time to time in the Companys public announcements and periodic filings with the US Securities and Exchange Commission on EDGAR
